Skip to Content
Merck
CN
All Photos(1)

Documents

EPS001

Sigma-Aldrich

HAT Activator, CTPB

A potent activator of HAT (histone acetyltransferase)

Synonym(s):

Benzamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-2-ethoxy-6-pentadecyl, CTPB, CTPB (enzyme activator), CTPB (enzyme inhibitor), N-(4-Chloro-3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C31H43ClF3NO2
CAS Number:
586976-24-1
Molecular Weight:
554.13
UNSPSC Code:
12352200

Assay

≥97% (H-NMR)

storage condition

desiccated
protect from light

color

white to off-white

solubility

DMSO: soluble

storage temp.

−20°C

InChI

1S/C31H43ClF3NO2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-18-24-19-17-20-28(38-4-2)29(24)30(37)36-25-21-22-27(32)26(23-25)31(33,34)35/h17,19-23H,3-16,18H2,1-2H3,(H,36,37)

InChI key

OYBMVMAXKOGYDC-UHFFFAOYSA-N

General description

(N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide) or CTPB, which is a non-polar compound, has been shown to enhance the neurite growth and survival of neuronal cell lines.
A potent activator of p300 HAT (histone acetyltransferase), but not of PCAF (p300/CBP-associated factor) HAT activities.

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Small molecule modulators of histone acetyltransferase p300
Karanam B et al.
The Journal of Biological Chemistry (2003)
A small molecule activator of p300/CBP histone acetyltransferase promotes survival and neurite growth in a cellular model of Parkinson?s disease
Shane VH et al.
Neurotoxicity Research, 30(3), 510-520 (2016)
Shufeng Li et al.
OncoTargets and therapy, 13, 12383-12395 (2020-12-11)
Cervical squamous cell carcinoma (CSCC) is responsible for 80-85% of cervical cancer. Cyclin B1 (CCNB1) represents a hub gene during the development of cervical cancer. However, the oncogenic role of CCNB1 in CSCC remains unclear. Our study aims to explore

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service